Gene identification by cDNA arrays in HPV-positive cervical cancer

Archives of Medical Research

Volumn 36, Issue 5, 2005, Pages 448-458

  Vázquez Ortíz, Guelaguetza ^a   Ciudad, Carlos J ^b   Piña, Patricia ^a   Vazquez, Karla ^a   Hidalgo, Alfredo ^a   Alatorre, Brenda ^a   Garcia, Jose A ^c   Salamanca, Fabio ^d   Peralta Rodriguez, Raul ^a   Rangel, Angélica ^a   Salcedo, Mauricio ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSIDAD LA SALLE   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

cDNA arrays; Expression; HPV; RT PCR

Indexed keywords

CLAUDIN 1; COMPLEMENTARY DNA; INTERLEUKIN 6; PROTEIN LAMC2; STROMELYSIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIUM; FEMALE; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INVASIVE CARCINOMA; MEDICAL TECHNOLOGY; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; WART VIRUS;

CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RANDOM ALLOCATION; UTERINE CERVICAL NEOPLASMS;

EID: 23744461563     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.04.016     Document Type: Article

References (58)

1. X. Bosch, M. Manos, N. Muñoz, M. Sherman, A. Jansen, M. Schiffman, V. Moreno, and C. Kurman Prevalence of human papillomavirus in cervical cancer: a worldwide perspective (IBSCC) study group J Natl Cancer Inst 87 1995 796 802
2. J. Walboomers, M. Jacobs, M. Manos, X. Bosch, A. Kummer, L. Meijer, and N. Muñoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
3. R. Herrero, A. Hildesheim, C. Bratti, M. Hutchinson, I. Balmaceda, M.D. Greenberg, M. Alfaro, R.D. Burk, S. Wacholder, M. Plummer, and M. Schiffman Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica J Natl Cancer Inst 92 2000 464 474
4. L. Villa, L. Sichero, P. Rahal, A. Ferenczy, T. Rohan, and D. Franco Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia J Gen Virol 81 2000 2959 2968
5. D. Meissner Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines J Gen Virol 80 1999 1725 1733
6. H. zur Hausen Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J Natl Cancer Inst 92 2000 690 698
7. A. Cullen, R. Reid, M. Campion, and A.T. Lorincz Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm J Virol 65 1991 606 612
8. S. Klaes, S. Woerner, R. Ridder, N. Wentzensen, M. Duerst, A. Schneider, B. Lotz, P. Melsheimer, and M. Doeberitz Detection of high risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes Cancer Res 59 1999 6132 6136
9. A. Bos, M. van Ballegooijen, G.J. van Oortmarssen, M. van Marle, J. Habbema, and E. Lynge Non-progression of cervical intraepithelial neoplasia estimated from population-screening data Br J Cancer 75 1997 124 130
10. G. Ho, R. Bierman, L. Beardsley, C. Chang, and L. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 1998 423 428
11. S. Kjaer, A. van der Brule, J. Bocj, P. Poll, G. Engholm, M. Sherman, J. Walboomers, and F. Meijer Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and non oncogenic HPV types? Cancer Epidemiol Biomark Prev 6 1997 799 805
12. A. McBride, H. Romanczuk, and P.M. Howley The papillomavirus E2 regulatory proteins J Biol Chem 266 1991 18411 18414
13. N. Scheffner, J. Huibregste, D. Viestra, and P. Howley The HPV-16 E6 and E6-AP complex functions as ubiquitin protein ligase in ubiquitination of p53 Cell 75 1993 495 505
14. B. Werness, J. Levine, and P. Howley Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 1990 76 79
15. J. DeRisi, L. Penland, P. Brown, M. Britter, P. Meltzer, Y. Chen, and J. Trent Use of a cDNA microarray to analyse gene expression patterns in human cancer Nat Genet 4 1996 457 460
16. P. Brown, and R. Botstein Exploring the new world of the genome with DNA microarrays Nat Genet 21 Suppl 1999 33 37
17. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lonning, A.L. Borresen-Dale, P.O. Brown, and D. Botstein Molecular portrait of human breast tumours Nature 406 2000 747 752
18. C. Shim, W. Zhang, C. Hun, and J.H. Lee Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array Clin Cancer Res 4 1998 3045 3050
19. M. Nees, J. Geoghegan, T. Hyman, S. Frank, L. Miller, and R. Woodworth Papillomavirus type 16 oncogenes downregulate expression of interferon responsive genes and upregulate proliferation associated and NF-B-responsive genes in cervical keratinocytes J Virol 75 2001 4283 4296
20. Y. Chen, C. Miller, R. Mosher, X. Zhao, J. Deeds, M. Morrissey, B. Bryant, D. Yang, R. Meyer, F. Cronin, B.S. Gostout, K. Smith-McCune, and R. Schlegel Identification of cervical cancer markers by cDNA and tissue microarrays Cancer Res 63 2003 1927 1935
21. J.R. Caceres-Cortes, J.A. Alvarado-Moreno, K. Waga, R. Rangel-Corona, A. Monroy-Garcia, L. Rocha-Zavaleta, J. Urdiales-Ramos, B. Weiss-Steider, A. Haman, P. Hugo, R. Brousseau, and T. Hoang Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemia Cancer Res 61 2001 6281 6289
22. R. Lopez-Marure, G. Gutierrez, C. Mendoza, J.L. Ventura, L. Sanchez, E. Reyes Maldonado, A. Zentella, and L.F. Montano Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis Biochem Biophys Res Commun 293 2002 1028 1036
23. G. Monroy, B. Trejo, S. Charon, J. Hernández-Montes, and P. Granados Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV infection Immunol Lett 67 1999 167 177
24. A.M. Garcia, V.F. Ortíz-Navarrete, M.L. Mora-Garcia, F. Flores-Borja, A. Diaz-Quinonez, A. Isibasi-Araujo, C. Trejo-Becerril, R. Chacon-Salinas, J. Hernandez-Montes, J. Granados-Arreola, C. de Leo, and B. Weiss-Steider Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection Immunol Lett 67 1999 167 177
25. M. Bequet-Romero, and O. Lòpez-Ocejo Angiogenesis modulators expression in cultured cell lines positives for HPV-16 oncoproteins Biochem Biophys Res Commun 277 2000 55 61
26. M. Eisen, P. Spellman, P. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 95 1998 14863 14868
27. T. Kishimoto The biology of interleukin-6 Blood 74 1998 1 10
28. H. Rochter, R. Holley, W. Andrews, J. Owen, and K. Miller The association of interleukin 6 with clinical and laboratory parameters of acute pelvic inflammatory disease Am J Obstet Gynecol 181 1999 940 944
29. T. Espevik, A. Wagge, A. Faxvaag, and M. Shalaby Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 beta and transforming growth factor beta Cell Immunol 126 1990 47 56
30. D. Eustace, X. Han, R. Gooding, A. Rowbottom, P. Riches, and E. Heyderman Interleukin-6 functions as an autocrine growth factor in cervical carcinoma in vitro Gynecol Oncol 50 1993 15 19
31. M. Tjiong, N. van der Vange, F. ten Kate, S.P. Tjiong-A-Hung, J. ter Schegget, M.P. Burger, and T.A. Out Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer Gynecol Oncol 73 1999 285 291
32. Wei L, Kuo M, Chen Ch, Cheng C, Hsieg C. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 2001;82:49-56.
33. C. Woodworth, and S. Simpson Comparative lymphokine secretion by cultured normal human cervical keratinocites, papillomavirus-immortalized and carcinoma cell lines Am J Pathol 142 1993 1544 1555
34. M. Iglesias, G. Plowman, and C. Woodworth Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus immortalized and carcinoma derived cervical cells in vitro Am J Pathol 146 1995 944 952
35. L. Angelo, M. Talpaz, and R. Kurzrock Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53 Cancer Res 62 2002 932 940
36. M. Scheffner, K. Munger, J.C. Byrne, and P.M. Howley The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines Proc Natl Acad Sci USA 88 1991 5523 5527
37. U. Sabthanum, A. Ray, and P. Seghal Repression of the interleukin 6 promoter by p53 and the retinoblastoma susceptibility gene product Proc Natl Acad Sci USA 88 1991 7605 7609
38. L. Margulies, and P. Sehgal Modulation of the human interleukin 6 promoters and transcription factor C/EBPβ activity by p53 species J Biol Chem 268 1993 15096 15100
39. E. Seto, A. Usheva, G. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A.J. Levine, and T. Shenk Wild type p53 binds to the TATA binding protein and represses transcription Proc Natl Acad Sci USA 89 1992 12028 12032
40. D. Leung, G. Cachianes, W. Kuang, D. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309
41. F. Kramer, K. White, M. Kubbies, K. Swisshelm, and B.H. Weber Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer Hum Genet 107 2000 249 256
42. L. Ye, T.A. Martin, C. Parr, C. Parr, G.M. Harrison, R.E. Mansel, and W.G. Jiang Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells J Cell Physiol 196 2003 362 369
43. T. Hoevel, R. Macek, K. Swisshelm, and M. Kubbies Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids Int J Cancer 108 2004 374 383
44. T. Hoevel, R. Macek, O. Mundigl, K. Swisshelm, and M. Kubbies Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells J Cell Physiol 191 2002 60 68
45. N. Miwa, M. Furuse, S. Tsukita, N. Niikawa, Y. Nakamura, and Y. Furukawa Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers Oncol Res 12 2000 469 476
46. U.G. Sathyanarayana, A. Padar, M. Suzuki, R. Maruyama, H. Shigematsu, J.T. Hsieh, E.P. Frenkel, and A.F. Gazdar Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features Clin Cancer Res 9 2003 6395 6400
47. T.H. Su, J.G. Chang, K.T. Yeh, T.H. Lin, T.P. Lee, J.C. Chen, and C.C. Lin Mutation analysis of CTNNB1 (beta-catenin) and AXIN1, the components of Wnt pathway, in cervical carcinomas Oncol Rep 10 2003 1195 1200
48. R. Manda, T. Kohno, T. Niki, T. Yamada, S. Takenoshita, H. Kuwano, and J. Yokota Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas Biochem Biophys Res Commun 275 2000 440 445
49. U.G. Sathyanarayana, R. Maruyama, A. Padar, M. Suzuki, J. Bondaruk, A. Sagalowsky, J.D. Minna, E.P. Frenkel, H.B. Grossman, B. Czerniak, and A.F. Gazdar Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes Cancer Res 64 2004 1425 1430
50. B. Skyldberg, S. Salo, E. Eriksson, U. Aspenblad, B. Moberger, K. Tryggvason, and G. Auer Laminin-5 as a marker of invasiveness in cervical lesions J Natl Cancer Inst 21 1999 1882 1887
51. Kohlberger P, Beneder Ch, Horvat R, Leodolter S, Breitenecker G. Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol 2003;3:391-394.
52. J.K. Habermann, K. Hellman, S. Freitag, K. Heselmeyer-Haddad, A.C. Hellstrom, K. Shah, G. Auer, and T. Ried A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina Cancer Genet Cytogenet 148 2004 7 13
53. Human Papillomaviruses Compendium. 1994. Los Alamos National Laboratory Theoretical Biology and Biophysics.
54. B.C. Sheu, H.C. Lien, H.N. Ho, H.H. Lin, S.N. Chow, S.C. Huang, and S.M. Hsu Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer Cancer Res 63 2003 6537 6542
55. J.H. Woo, J.H. Lim, Y.H. Kim, S.I. Suh, S. Min do, J.S. Chang, Y.H. Lee, J.W. Park, and T.K. Kwon Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction Oncogene 23 2004 1845 1853
56. M.A. Gaiotto, J. Focchi, J.L. Ribalta, J.N. Stavale, E.C. Baracat, G.R. Lima, and I.D. Guerreiro da Silva Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma Am J Obstet Gynecol 190 2004 1278 1282
57. D. Muller, B. Quantin, M. Gesnel, R. Millon-Collard, J. Abecassis, and R. Breathnach The collagenase gene family in humans consists of at least four members Biochem J 253 1988 187 192
58. T. Sato, T. Sakai, Y. Noguchi, M. Takita, S. Hirakawa, and A. Ito Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases Gynecol Oncol 92 2004 47 56